Thioperamide

Drug Profile

Thioperamide

Latest Information Update: 01 Nov 1999

Price : $50

At a glance

  • Originator GlaxoSmithKline
  • Class Antiarrhythmics; Antihistamines; Nootropics
  • Mechanism of Action Histamine H3 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Arrhythmias; Cognition disorders

Most Recent Events

  • 01 Nov 1999 Discontinued-Preclinical for Cognition disorders in United Kingdom (Unknown route)
  • 01 Nov 1999 Discontinued-Preclinical for Arrhythmias in United Kingdom (Unknown route)
  • 23 Apr 1997 No-Development-Reported for Arrhythmias in United Kingdom (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top